{"pre_text": ["jpmorgan chase & co./2017 annual report 115 impact of wrong-way risk , which is broadly defined as the potential for increased correlation between the firm 2019s exposure to a counterparty ( avg ) and the counterparty 2019s credit quality .", "many factors may influence the nature and magnitude of these correlations over time .", "to the extent that these correlations are identified , the firm may adjust the cva associated with that counterparty 2019s avg .", "the firm risk manages exposure to changes in cva by entering into credit derivative transactions , as well as interest rate , foreign exchange , equity and commodity derivative transactions .", "the accompanying graph shows exposure profiles to the firm 2019s current derivatives portfolio over the next 10 years as calculated by the peak , dre and avg metrics .", "the three measures generally show that exposure will decline after the first year , if no new trades are added to the portfolio .", "exposure profile of derivatives measures december 31 , 2017 ( in billions ) the following table summarizes the ratings profile by derivative counterparty of the firm 2019s derivative receivables , including credit derivatives , net of all collateral , at the dates indicated .", "the ratings scale is based on the firm 2019s internal ratings , which generally correspond to the ratings as assigned by s&p and moody 2019s .", "ratings profile of derivative receivables ."], "post_text": ["as previously noted , the firm uses collateral agreements to mitigate counterparty credit risk .", "the percentage of the firm 2019s over-the-counter derivatives transactions subject to collateral agreements 2014 excluding foreign exchange spot trades , which are not typically covered by collateral agreements due to their short maturity and centrally cleared trades that are settled daily 2014 was approximately 90% ( 90 % ) as of december 31 , 2017 , largely unchanged compared with december 31 , 2016 .", "credit derivatives the firm uses credit derivatives for two primary purposes : first , in its capacity as a market-maker , and second , as an end-user to manage the firm 2019s own credit risk associated with various exposures .", "for a detailed description of credit derivatives , see credit derivatives in note 5 .", "credit portfolio management activities included in the firm 2019s end-user activities are credit derivatives used to mitigate the credit risk associated with traditional lending activities ( loans and unfunded commitments ) and derivatives counterparty exposure in the firm 2019s wholesale businesses ( collectively , 201ccredit portfolio management 201d activities ) .", "information on credit portfolio management activities is provided in the table below .", "for further information on derivatives used in credit portfolio management activities , see credit derivatives in note 5 .", "the firm also uses credit derivatives as an end-user to manage other exposures , including credit risk arising from certain securities held in the firm 2019s market-making businesses .", "these credit derivatives are not included in credit portfolio management activities ; for further information on these credit derivatives as well as credit derivatives used in the firm 2019s capacity as a market-maker in credit derivatives , see credit derivatives in note 5 .", "10 years5 years2 years1 year ."], "table": [["rating equivalent december 31 ( in millions except ratios )", "rating equivalent exposure net of all collateral", "rating equivalent % (  % ) of exposure netof all collateral", "exposure net of all collateral", "% (  % ) of exposure netof all collateral"], ["aaa/aaa to aa-/aa3", "$ 11529", "29% ( 29 % )", "$ 11449", "28% ( 28 % )"], ["a+/a1 to a-/a3", "6919", "17", "8505", "20"], ["bbb+/baa1 to bbb-/baa3", "13925", "34", "13127", "32"], ["bb+/ba1 to b-/b3", "7397", "18", "7308", "18"], ["ccc+/caa1 and below", "645", "2", "984", "2"], ["total", "$ 40415", "100% ( 100 % )", "$ 41373", "100% ( 100 % )"]], "table_ori": [["Rating equivalent", "2017", "2016"], ["December 31,(in millions, except ratios)", "Exposure net of all collateral", "% of exposure netof all collateral", "Exposure net of all collateral", "% of exposure netof all collateral"], ["AAA/Aaa to AA-/Aa3", "$11,529", "29%", "$11,449", "28%"], ["A+/A1 to A-/A3", "6,919", "17", "8,505", "20"], ["BBB+/Baa1 to BBB-/Baa3", "13,925", "34", "13,127", "32"], ["BB+/Ba1 to B-/B3", "7,397", "18", "7,308", "18"], ["CCC+/Caa1 and below", "645", "2", "984", "2"], ["Total", "$40,415", "100%", "$41,373", "100%"]]}

Question: in 2017 what was the percent of the total exposure net of all collateral that was a+/a1 to a-/a3
Evidence:
table_2: rating equivalent december 31 ( in millions except ratios ) the a+/a1 to a-/a3 of rating equivalent exposure net of all collateral is 6919 ; the a+/a1 to a-/a3 of rating equivalent % ( % ) of exposure netof all collateral is 17 ; the a+/a1 to a-/a3 of exposure net of all collateral is 8505 ; the a+/a1 to a-/a3 of % ( % ) of exposure netof all collateral is 20 ;
table_6: rating equivalent december 31 ( in millions except ratios ) the total of rating equivalent exposure net of all collateral is $ 40415 ; the total of rating equivalent % ( % ) of exposure netof all collateral is 100% ( 100 % ) ; the total of exposure net of all collateral is $ 41373 ; the total of % ( % ) of exposure netof all collateral is 100% ( 100 % ) ;
Program: divide(6919, 40415)
Answer:
str_answer: 17.1%
exe_answer: 0.1712